Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 56%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is positioned for strong growth due to its strategic investment in the USPI segment, which offers higher margins and returns, contributing to improved return on invested capital (ROIC). The company's focus on outpatient growth opportunities, alongside a favorable payer mix and lower labor costs, suggests significant potential for enterprise-wide margin expansion. Additionally, an anticipated rise in income from equity earnings in 2026, bolstered by favorable volume trends and state supplemental payments, reinforces a positive outlook for Tenet Healthcare.

Bears say

Tenet Healthcare's stock outlook is negatively impacted by significant potential headwinds associated with the expiration of subsidies, with an estimated $220 million adverse effect on its Acute segment and another $30 million on its USPI segment for 2026 forecasts. Additionally, the company faces challenges from a projected 20% decline in Health Insurance Exchange coverage, which could result in 80-85% of these individuals becoming uninsured, further decreasing patient utilization. Though Tenet recorded a one-time gain of $148 million from Medicaid state funds in 2025, the reliance on such non-recurring revenue raises concerns about the sustainability of its financial performance moving forward.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 56% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.28, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.28, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.